Clinical trial
Explore Potential Plasma Biomarkers of Acute Respiratory Distress Syndrome (ARDS) Using Proteomics Analysis in Patients Undergoing Cardiopulmonary Bypass
NCT04696172 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Explore Potential Plasma Biomarkers of Acute Respiratory Distress Syndrome (ARDS) Using Proteomics Analysis in Patients Undergoing Cardiopulmonary Bypass
- Lead sponsor
- Huazhong University of Science and Technology
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- August 30, 2022
- Enrollment
- 525 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory distress syndrome